Chr. Hansen plans to strengthen biological solutions amid 7% organic growth in 2020/2021
date:Oct 15, 2021
gment. This was as expected due to higher comparables as customers built safety inventories during lockdowns throughout the pandemic.

Limited customer access, delayed registration times, and general macroeconomic uncertainty restrained growth opportunities, and our Human Health business disappointed in the second half of the year due to the part of the business serving the traditional sales channels, Graber explains.

In light of this, he further highlights an all-time-high product launch activ
3/10 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/25 22:32